Dental AI Adoption in 2026: What the ADA Survey Shows

Editorial correction (October 12, 2026): An earlier version stated or implied that Avized had a proprietary dataset or empirical results without supplying the underlying records. Those assertions have been withdrawn. This replacement distinguishes published research, vendor announcements, and illustrative planning models.

ADA survey: adoption is uneven by workflow

The previous version of this article asserted a $1 billion annual dental AI market and more than 100 million radiographs processed by named vendors without citing a reproducible source. Those statements have been removed.

The ADA Health Policy Institute's July 2026 analysis, based on its survey panel of U.S. dentists, provides a better starting point. According to the published survey, 43.3% of responding dentists reported using AI for at least one practice task. Another 26.4% said they were planning future use.

These numbers describe responding dentists, not audited installation counts or the percentage of practices with paid dental AI contracts.

Reported areas of use

The same HPI summary reports:

• 22.8% of responding dentists using AI for imaging and diagnostics
• 13.6% for insurance verification
• 13.2% for explaining clinical findings to patients
• 10.1% for business analytics
• 10.1% for reception or front-desk check-in
• Less than 5% for patient treatment recommendations

These uses can overlap. They should not be summed to calculate the share of dentists using AI.

What buyers can conclude

Administrative workflows and clinical support uses are not equivalent. An AI assistant used for answering calls, a radiographic image-analysis device, and software that recommends treatments differ in validation requirements, workflow risks and the role of human judgment.

The ADA analysis indicates substantially more appetite for AI assistance with some administrative and imaging tasks than for automated treatment recommendations. It does not prove a particular vendor's market share, revenue, clinical benefit or practice ROI.

For clinical imaging products, review the ADA AI standards and check a product's specific FDA marketing-authorization status where relevant.

How Avized should track adoption over time

Store survey publisher, survey period, respondent population, exact question text, sample size when disclosed, definitions of AI, and geographic scope. If a vendor provides customer figures, label them as vendor-reported, with a date and source. Keep those measures separate from independent national survey results.

Bottom line: AI use is meaningful in U.S. dental practices, but adoption varies by task. The ADA's published data is more reliable than unsupported market estimates.